{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:40:12Z","timestamp":1790959212463,"version":"4.1.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Anterior cruciate ligament <jats:bold>(<\/jats:bold>ACL) reconstruction (ACLR) surgery remains the prevailing standard of care for complete ACL ruptures but is not without risk. The aim of this study was to compare non-surgical, autologous bone marrow concentrate (BMC) with platelet products compared to exercise therapy for partial and complete, non-retracted ACL tears without meniscus injuries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this randomized-controlled, crossover trial, patients received either exercise therapy or an injection of BMC with platelet products to treat ACL tears. After 3 months, if patients randomized to the exercise group were not satisfied with their improvement, they could crossover to receive the BMC treatment. Patients reported outcomes were completed at pre-treatment, 1-, 3, 6-, 12-, and 24-months of the Numeric Pain Scale (NPS), the International Knee Documentation Committee (IKDC) subjective knee form, Lower Extremity Function Scale (LEFS), and a modified Single Assessment Numeric Evaluation (SANE). MRIs at pre- and post-treatment were assessed using ImageJ software analysis. Complications and surgeries were assessed at each time point.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Patients in the BMC group reported significantly greater change scores (from pre-treatment) on LEFS (<jats:italic>P<\/jats:italic>\u2009=\u20090.027), and SANE (<jats:italic>P<\/jats:italic>\u2009=\u20090.007) at 3 months compared to the exercise group. No significant differences were found between baseline and\/or 1- month and 3-month follow-ups for any outcome measure (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05) in the exercise therapy group. When followed through 2 years, patients who received BMC treatment demonstrated sustained improvements in function and decreases in pain, with patients reporting a median of subjective improvement (SANE) of 90% at the final follow-up. Significant negative correlations were found between age of injury and \u0394IKDC \u0394LEFS, and SANE (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) at the 24-month follow-up with lower \u0394PROMs reported by those with older tears the age of tear (&gt;\u200912 months). Post-treatment MRI provided evidence of significant improvements in ACL integrity. No serious adverse events were reported. Four patients did not respond to BMC treatment and underwent ACL reconstruction without any new reports of knee injuries.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The significant improvements in function, pain, and overall improvement in patients receiving BMC and platelets provide evidence of a viable alternative treatment option for patients with ACL tears.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>NCT01850758; A Randomized Controlled Trial of Regenexx-SD Versus Exercise therapy for Treatment of Partial and Complete, Non-retracted Anterior Cruciate Ligament Tears. Registered May 7, 2013.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12891-025-09153-2","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:09:08Z","timestamp":1759230548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Non-surgical treatment of anterior cruciate ligament tears with percutaneous bone marrow concentrate and platelet products versus exercise therapy: a randomized-controlled, crossover trial with 2-year follow-up"],"prefix":"10.1186","volume":"26","author":[{"given":"Christopher J.","family":"Centeno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin R.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Markle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Pelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehren","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"4","key":"9153_CR1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/JSM.0b013e3182580cd0","volume":"22","author":"L Siegel","year":"2012","unstructured":"Siegel L, Vandenakker-Albanese C, Siegel D. Anterior cruciate ligament injuries: anatomy, physiology, biomechanics, and management. Clin J Sport Med. 2012;22(4):349\u201355.","journal-title":"Clin J Sport Med"},{"issue":"9","key":"9153_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1002\/jor.25128","volume":"39","author":"MM Murray","year":"2021","unstructured":"Murray MM. Optimizing outcomes of ACL surgery-is autograft reconstruction the only reasonable option? J Orthop Res. 2021;39(9):1843\u201350.","journal-title":"J Orthop Res"},{"issue":"10","key":"9153_CR3","doi-asserted-by":"publisher","first-page":"364","DOI":"10.21037\/atm-23-87","volume":"11","author":"R D\u2019Ambrosi","year":"2023","unstructured":"D\u2019Ambrosi R, Meena A, Arora ES, Attri M, Sch\u00e4fer L, Migliorini F. Reconstruction of the anterior cruciate ligament: a historical view. Ann Transl Med. 2023;11(10):364.","journal-title":"Ann Transl Med"},{"issue":"1","key":"9153_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12178-019-09596-w","volume":"13","author":"EC Cheung","year":"2020","unstructured":"Cheung EC, DiLallo M, Feeley BT, Lansdown DA. Osteoarthritis and ACL reconstruction-myths and risks. Curr Rev Musculoskelet Med. 2020;13(1):115\u201322.","journal-title":"Curr Rev Musculoskelet Med"},{"issue":"5","key":"9153_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2325967119845313","volume":"7","author":"BU Nwachukwu","year":"2019","unstructured":"Nwachukwu BU, Adjei J, Rauck RC, Chahla J, Okoroha KR, Verma NN, et al. How much do psychological factors affect lack of return to play after anterior cruciate ligament reconstruction?? A systematic review. Orthop J Sports Med. 2019;7(5):2325967119845313.","journal-title":"Orthop J Sports Med"},{"issue":"21","key":"9153_CR6","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/bjsports-2013-093398","volume":"48","author":"CL Ardern","year":"2014","unstructured":"Ardern CL, Taylor NF, Feller JA, Webster KE. Fifty-five per cent return to competitive sport following anterior cruciate ligament reconstruction surgery: an updated systematic review and meta-analysis including aspects of physical functioning and contextual factors. Br J Sports Med. 2014;48(21):1543\u201352.","journal-title":"Br J Sports Med"},{"issue":"6","key":"9153_CR7","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s11033-020-05428-0","volume":"47","author":"C Eder","year":"2020","unstructured":"Eder C, Schmidt-Bleek K, Geissler S, Sass FA, Maleitzke T, Pumberger M, et al. Mesenchymal stromal cell and bone marrow concentrate therapies for musculoskeletal indications: a concise review of current literature. Mol Biol Rep. 2020;47(6):4789\u2013814.","journal-title":"Mol Biol Rep"},{"key":"9153_CR8","doi-asserted-by":"publisher","DOI":"10.1051\/sicotj\/2017007","volume":"3","author":"MA Imam","year":"2017","unstructured":"Imam MA, Mahmoud SSS, Holton J, Abouelmaati D, Elsherbini Y, Snow M. A systematic review of the concept and clinical applications of bone marrow aspirate concentrate in orthopaedics. SICOT-J. 2017;3:17.","journal-title":"SICOT-J"},{"issue":"2","key":"9153_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/23259671211066504","volume":"10","author":"KN Kunze","year":"2022","unstructured":"Kunze KN, Pakanati JJ, Vadhera AS, Polce EM, Williams BT, Parvaresh KC, et al. The efficacy of platelet-rich plasma for ligament injuries: a systematic review of basic science literature with protocol quality assessment. Orthop J Sports Med. 2022;10(2):23259671211066504.","journal-title":"Orthop J Sports Med"},{"issue":"4","key":"9153_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1902\/jop.2007.060302","volume":"78","author":"H El-Sharkawy","year":"2007","unstructured":"El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, et al. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007;78(4):661\u20139.","journal-title":"J Periodontol"},{"issue":"7","key":"9153_CR11","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/jcp.25255","volume":"231","author":"AI Caplan","year":"2016","unstructured":"Caplan AI, MSCs. The Sentinel and Safe-Guards of injury. J Cell Physiol. 2016;231(7):1413\u20136.","journal-title":"J Cell Physiol"},{"key":"9153_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.actbio.2020.01.051","volume":"106","author":"H Yu","year":"2020","unstructured":"Yu H, Cheng J, Shi W, Ren B, Zhao F, Shi Y, et al. Bone marrow mesenchymal stem cell-derived exosomes promote tendon regeneration by facilitating the proliferation and migration of endogenous tendon stem\/progenitor cells. Acta Biomater. 2020;106:328\u201341.","journal-title":"Acta Biomater"},{"issue":"2","key":"9153_CR13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/cpr.12242","volume":"49","author":"ZC Hao","year":"2016","unstructured":"Hao ZC, Wang SZ, Zhang XJ, Lu J. Stem cell therapy: a promising biological strategy for tendon-bone healing after anterior cruciate ligament reconstruction. Cell Prolif. 2016;49(2):154\u201362.","journal-title":"Cell Prolif"},{"issue":"7","key":"9153_CR14","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/j.arthro.2022.01.010","volume":"38","author":"B Forsythe","year":"2022","unstructured":"Forsythe B, Chahla J, Korrapati A, Lavoie-Gagne O, Forlenza E, Diaz CC, et al. Bone marrow aspirate concentrate augmentation may accelerate allograft ligamentization in anterior cruciate ligament reconstruction: a double-blinded randomized controlled trial. Arthroscopy. 2022;38(7):2255\u201364.","journal-title":"Arthroscopy"},{"issue":"1","key":"9153_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-023-04512-y","volume":"19","author":"YC Lin","year":"2024","unstructured":"Lin YC, Chen YJ, Fan TY, Chou PH, Lu CC. Effect of bone marrow aspiration concentrate and platelet-rich plasma combination in anterior cruciate ligament reconstruction: a randomized, prospective, double-blinded study. J Orthop Surg Res. 2024;19(1):4.","journal-title":"J Orthop Surg Res"},{"issue":"1","key":"9153_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1391-0","volume":"19","author":"Y Wang","year":"2017","unstructured":"Wang Y, Shimmin A, Ghosh P, Marks P, Linklater J, Connell D, et al. Safety, tolerability, clinical, and joint structural outcomes of a single intra-articular injection of allogeneic mesenchymal precursor cells in patients following anterior cruciate ligament reconstruction: a controlled double-blind randomised trial. Arthritis Res Ther. 2017;19(1):180.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"9153_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1623-3","volume":"16","author":"C Centeno","year":"2018","unstructured":"Centeno C, Markle J, Dodson E, Stemper I, Williams C, Hyzy M, et al. Symptomatic anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow concentrate and platelet products: a non-controlled registry study. J Transl Med. 2018;16(1):246.","journal-title":"J Transl Med"},{"key":"9153_CR18","first-page":"437","volume":"8","author":"CJ Centeno","year":"2015","unstructured":"Centeno CJ, Pitts J, Al-Sayegh H, Freeman MD. Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series. J Pain Res. 2015;8:437\u201347.","journal-title":"J Pain Res"},{"issue":"SP2","key":"9153_CR19","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.22374\/boj.v3iSP2.24","volume":"3","author":"C Centeno","year":"2022","unstructured":"Centeno C, Lucas M, Stemper I, Dodson E. Image guided injection of anterior cruciate ligament tears with autologous bone marrow concentrate and platelets: midterm analysis from a randomized controlled trial. Biol Orthop J. 2022;3(SP2):e7-20.","journal-title":"Biol Orthop J"},{"issue":"4","key":"9153_CR20","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.pmr.2016.06.009","volume":"27","author":"MF Friedlis","year":"2016","unstructured":"Friedlis MF, Centeno CJ. Performing a better bone marrow aspiration. Phys Med Rehabil Clin N Am. 2016;27(4):919\u201339.","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"1","key":"9153_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-017-0113-5","volume":"4","author":"C Centeno","year":"2017","unstructured":"Centeno C, Markle J, Dodson E, Stemper I, Hyzy M, Williams C, et al. The use of lumbar epidural injection of platelet lysate for treatment of radicular pain. J Exp Orthop. 2017;4(1):38.","journal-title":"J Exp Orthop"},{"issue":"5","key":"9153_CR22","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1177\/03635465010290051301","volume":"29","author":"JJ Irrgang","year":"2001","unstructured":"Irrgang JJ, Anderson AF, Boland AL, Harner CD, Kurosaka M, Neyret P, et al. Development and validation of the international knee Documentation committee subjective knee form. Am J Sports Med. 2001;29(5):600\u201313.","journal-title":"Am J Sports Med"},{"issue":"4","key":"9153_CR23","first-page":"371","volume":"79","author":"JM Binkley","year":"1999","unstructured":"Binkley JM, Stratford PW, Lott SA, Riddle DL, North American orthopaedic rehabilitation research network. The lower extremity functional scale (LEFS): scale development, measurement properties, and clinical application. Phys Ther. 1999;79(4):371\u201383.","journal-title":"Phys Ther"},{"key":"9153_CR24","doi-asserted-by":"crossref","unstructured":"Farrar JT, Young JP Jr., LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149\u201358.","DOI":"10.1016\/S0304-3959(01)00349-9"},{"issue":"7","key":"9153_CR25","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"key":"9153_CR26","doi-asserted-by":"crossref","unstructured":"Nwachukwu BU, Sullivan SW, Rauck RC, James EW, Burger JA, Altchek DW et al. Patient-Reported outcomes and factors associated with achieving the minimal clinically important difference after ACL reconstruction: results at a mean 7.7-Year Follow-up. JB JS Open Access. 2021;6(4):e2100056.","DOI":"10.2106\/JBJS.OA.21.00056"},{"issue":"3","key":"9153_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/JSM.0b013e31824cb53d","volume":"22","author":"GK Alcock","year":"2012","unstructured":"Alcock GK, Werstine MS, Robbins SM, Stratford PW. Longitudinal changes in the lower extremity functional scale after anterior cruciate ligament reconstructive surgery. Clin J Sport Med. 2012;22(3):234\u20139.","journal-title":"Clin J Sport Med"},{"key":"9153_CR28","doi-asserted-by":"publisher","first-page":"851","DOI":"10.2147\/JPR.S158847","volume":"11","author":"AH Alghadir","year":"2018","unstructured":"Alghadir AH, Anwer S, Iqbal A, Iqbal ZA. Test-retest reliability, validity, and minimum detectable change of visual analog, numerical rating, and verbal rating scales for measurement of Osteoarthritic knee pain. J Pain Res. 2018;11:851\u20136.","journal-title":"J Pain Res"},{"issue":"8","key":"9153_CR29","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1007\/s00264-018-3791-4","volume":"42","author":"J Murgier","year":"2018","unstructured":"Murgier J, Beranger JS, Boisrenoult P, Steltzlen C, Pujol N. Prospective comparative study of knee laxity with four different methods in anterior cruciate ligament tears. Int Orthop. 2018;42(8):1845\u201351.","journal-title":"Int Orthop"},{"issue":"3","key":"9153_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00167-010-1205-2","volume":"19","author":"OG Sorensen","year":"2011","unstructured":"Sorensen OG, Larsen K, Jakobsen BW, Kold S, Hansen TB, Lind M, et al. The combination of radiostereometric analysis and the Telos stress device results in poor precision for knee laxity measurements after anterior cruciate ligament reconstruction. Knee Surg Sports Traumatol Arthrosc. 2011;19(3):355\u201362.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"key":"9153_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144567","author":"A Deichsel","year":"2023","unstructured":"Deichsel A, Oeckenpohler S, Raschke MJ, Grunenberg O, Peez C, Briese T, et al. Recurrent instability rate and subjective knee function following accelerated rehabilitation after ACL reconstruction in comparison to a conservative rehabilitation protocol. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12144567.","journal-title":"J Clin Med"},{"issue":"23","key":"9153_CR32","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bjsports-2023-106931","volume":"57","author":"SR Filbay","year":"2023","unstructured":"Filbay SR, Dowsett M, Chaker Jomaa M, Rooney J, Sabharwal R, Lucas P, et al. Healing of acute anterior cruciate ligament rupture on MRI and outcomes following non-surgical management with the cross bracing protocol. Br J Sports Med. 2023;57(23):1490\u20137.","journal-title":"Br J Sports Med"},{"issue":"2","key":"9153_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/bjsports-2022-105473","volume":"57","author":"SR Filbay","year":"2023","unstructured":"Filbay SR, Roemer FW, Lohmander LS, Turkiewicz A, Roos EM, Frobell R, et al. Evidence of ACL healing on MRI following ACL rupture treated with rehabilitation alone May be associated with better patient-reported outcomes: a secondary analysis from the KANON trial. Br J Sports Med. 2023;57(2):91\u20138.","journal-title":"Br J Sports Med"},{"key":"9153_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2023.102226","author":"A Saraf","year":"2023","unstructured":"Saraf A, Hussain A, Singhal A, Arora V, Bishnoi S. Do age, gender, BMI and disease duration influence the clinical outcomes in patients of knee osteoarthritis treated with serial injections of autologous platelet rich plasma? J Clin Orthop Trauma. 2023. https:\/\/doi.org\/10.1016\/j.jcot.2023.102226.","journal-title":"J Clin Orthop Trauma"},{"issue":"2","key":"9153_CR35","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00167-013-2384-4","volume":"22","author":"N Lefevre","year":"2014","unstructured":"Lefevre N, Bohu Y, Naouri JF, Klouche S, Herman S. Validity of GNRB\u00ae arthrometer compared to telos\u2122 in the assessment of partial anterior cruciate ligament tears. Knee Surg Sports Traumatol Arthrosc. 2014;22(2):285\u201390.","journal-title":"Knee Surg Sports Traumatol Arthrosc"},{"issue":"8","key":"9153_CR36","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.arthro.2005.04.110","volume":"21","author":"L Salmon","year":"2005","unstructured":"Salmon L, Russell V, Musgrove T, Pinczewski L, Refshauge K. Incidence and risk factors for graft rupture and contralateral rupture after anterior cruciate ligament reconstruction. Arthroscopy. 2005;21(8):948\u201357.","journal-title":"Arthroscopy"},{"issue":"3","key":"9153_CR37","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/JSM.0000000000000202","volume":"26","author":"N Mohtadi","year":"2016","unstructured":"Mohtadi N, Barber R, Chan D, Paolucci EO. Complications and adverse events of a randomized clinical trial comparing 3 graft types for ACL reconstruction. Clin J Sport Med. 2016;26(3):182\u20139.","journal-title":"Clin J Sport Med"},{"issue":"3","key":"9153_CR38","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/0363546511430375","volume":"40","author":"T Leys","year":"2012","unstructured":"Leys T, Salmon L, Waller A, Linklater J, Pinczewski L. Clinical results and risk factors for reinjury 15 years after anterior cruciate ligament reconstruction: a prospective study of hamstring and patellar tendon grafts. Am J Sports Med. 2012;40(3):595\u2013605.","journal-title":"Am J Sports Med"},{"issue":"4","key":"9153_CR39","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1177\/0363546506296042","volume":"35","author":"LA Pinczewski","year":"2007","unstructured":"Pinczewski LA, Lyman J, Salmon LJ, Russell VJ, Roe J, Linklater J. A 10-year comparison of anterior cruciate ligament reconstructions with hamstring tendon and patellar tendon autograft: a controlled, prospective trial. Am J Sports Med. 2007;35(4):564\u201374.","journal-title":"Am J Sports Med"},{"issue":"5","key":"9153_CR40","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1302\/0301-620X.105B5.BJJ-2022-1064.R1","volume":"105\u2013b","author":"PM Inclan","year":"2023","unstructured":"Inclan PM, Brophy RH. Revision anterior cruciate ligament reconstruction. Bone Joint J. 2023;105\u2013b(5):474\u201380.","journal-title":"Bone Joint J"},{"key":"9153_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s11547-025-01973-5","author":"R D\u2019Ambrosi","year":"2025","unstructured":"D\u2019Ambrosi R, Sconfienza LM, Albano D, Meena A, Abermann E, Fink C. Can MRI predict return to sport after anterior cruciate ligament reconstruction? A systematic review of the literature. Radiol Med. 2025. https:\/\/doi.org\/10.1007\/s11547-025-01973-5.","journal-title":"Radiol Med"},{"issue":"11","key":"9153_CR42","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1177\/0363546519861393","volume":"47","author":"SGF Abram","year":"2019","unstructured":"Abram SGF, Judge A, Beard DJ, Price AJ. Rates of adverse outcomes and revision surgery after anterior cruciate ligament reconstruction: a study of 104,255 procedures using the National hospital episode statistics database for England, UK. Am J Sports Med. 2019;47(11):2533\u201342.","journal-title":"Am J Sports Med"},{"issue":"2","key":"9153_CR43","doi-asserted-by":"publisher","first-page":"e12017","DOI":"10.1002\/jeo2.12017","volume":"11","author":"R D\u2019Ambrosi","year":"2024","unstructured":"D\u2019Ambrosi R, Carrozzo A, Meena A, Corona K, Yadav AK, Annibaldi A, et al. A slight degree of osteoarthritis appears to be present after anterior cruciate ligament reconstruction compared with contralateral healthy knees at a minimum of 20 years: A systematic review of the literature. J Exp Orthop. 2024;11(2):e12017.","journal-title":"J Exp Orthop"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12891-025-09153-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-025-09153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:09:11Z","timestamp":1759230551000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-025-09153-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9153"],"URL":"https:\/\/doi.org\/10.1186\/s12891-025-09153-2","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"13 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the International Cellular Medicine Society Institutional Review Board (OHRP #IRB00002637, Approval number: ICMS-2013-0015, date: 04\/22\/2013). All patients signed informed consent before participating in the trial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"One or more of the authors has declared a potential conflict of interest. DRB, MM, and ED are employed by Regenexx, LLC. CJC is a shareholder, patent holder, and Chief Medical Officer of Regenexx, LLC and an owner of the Centeno-Schultz Clinic. JP, JM, and AJP are employed by the Centeno-Schultz Clinic.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"882"}}